Structures by: Kaulgud T.
Total: 19
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--1,4-diazabicyclo[2.2.2]octane (2/1)
2(C12H14N4O2S),C6H12N2
Acta Crystallographica Section E (2013) 69, 11 o1615
a=26.488(3)Å b=9.7886(11)Å c=12.2163(13)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4,6-Dimethylpyrimidin-2-yl)-4-(oxolan-2-ylamino)benzenesulfonamide
C16H20N4O3S
Acta Crystallographica Section E (2009) 65, 11 o2851
a=10.291(5)Å b=9.592(4)Å c=17.196(8)Å
α=90° β=106.445(10)° γ=90°
4,4'-Bipyridine--pyroglutamic acid (1/2)
C10H8N2,2(C5H7NO3)
Acta Crystallographica Section E (2009) 65, 11 o2950
a=7.444(3)Å b=11.511(4)Å c=12.845(4)Å
α=66.274(17)° β=74.203(17)° γ=86.91(2)°
Benzoic acid--2,9-dimethylphenanthroline (1/1)
C7H6O2,C14H12N2
Acta Crystallographica Section E (2010) 66, 8 o2117
a=13.575(5)Å b=11.645(4)Å c=11.148(4)Å
α=90° β=104.832(6)° γ=90°
2-(4-Chlorophenyl)acetic acid--2-{(<i>E</i>)-[(<i>E</i>)-2-(2-pyridylmethylidene)hydrazin-1- ylidene]methyl}pyridine (1/1)
C8H7ClO2,C12H10N4
Acta Crystallographica Section E (2010) 66, 9 o2356
a=11.740(6)Å b=4.641(2)Å c=33.451(15)Å
α=90° β=90° γ=90°
1,2,4,5-Tetrafluoro-3,6-diiodobenzene--2,3-bis(pyridin-2-yl)pyrazine (1/1)
C14H10N4,C6F4I2
Acta Crystallographica Section E (2010) 66, 11 o2885
a=6.3997(15)Å b=10.737(2)Å c=15.092(4)Å
α=74.237(10)° β=85.877(11)° γ=80.283(12)°
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--benzoic acid (1/1)
C12H14N4O2S,C7H6O2
Acta Crystallographica Section E (2010) 66, 9 o2430
a=15.203(6)Å b=14.006(5)Å c=18.015(7)Å
α=90° β=90° γ=90°
1,2,4,5-Tetrafluoro-3,6-diiodobenzene--4-(pyridin-4-ylsulfanyl)pyridine (1/1)
C10H8N2S,C6F4I2
Acta Crystallographica Section E (2010) 66, 10 o2683
a=13.804(5)Å b=5.829(2)Å c=22.164(8)Å
α=90° β=97.989(7)° γ=90°
2-Phenylacetic acid--3-{(<i>E</i>)-2-[(<i>E</i>)-pyridin-3-ylmethylidene]hydrazin-1- ylidenemethyl}pyridine (2/1)
C12H10N4,2(C8H8O2)
Acta Crystallographica Section E (2010) 66, 10 o2684
a=5.511(2)Å b=9.536(4)Å c=12.434(6)Å
α=80.30(2)° β=88.45(3)° γ=76.46(2)°
Benzoic acid--4-{(1<i>E</i>)-[(<i>E</i>)-2-(pyridin-4-ylmethylidene)hydrazin- 1-ylidene]methyl}pyridine (2/1)
C12H10N4,2(C7H6O2)
Acta Crystallographica Section E (2010) 66, 11 o2924
a=6.873(6)Å b=26.059(19)Å c=7.117(6)Å
α=90° β=116.245(13)° γ=90°
Benzoic acid--2-{(<i>E</i>)-[(<i>E</i>)-2-(2-pyridylmethylidene)hydrazin-1- ylidene]methyl}pyridine (2/1)
C12H10N4,2(C7H6O2)
Acta Crystallographica Section E (2010) 66, 11 o2813
a=4.4509(7)Å b=11.3635(17)Å c=12.0612(17)Å
α=108.985(6)° β=99.830(9)° γ=97.849(10)°
2-Phenylacetic acid--(<i>E</i>,<i>E</i>)-4,4'-(hydrazinediylidene)dipyridine (2/1)
C12H10N4,2(C8H8O2)
Acta Crystallographica Section E (2010) 66, 10 o2629
a=11.677(7)Å b=4.425(2)Å c=23.587(13)Å
α=90.00° β=95.475(8)° γ=90.00°
2,2'-(Disulfanediyl)dibenzoic acid--2,9-dimethylphenanthroline--tetrahydrofuran (1/2/1)
C14H10O4S2,2(C14H12N2),C4H8O
Acta Crystallographica Section E (2010) 66, 10 o2602
a=14.011(4)Å b=8.516(3)Å c=17.403(5)Å
α=90° β=109.637(6)° γ=90°
Bis(2,9-dimethyl-1,10-phenanthrolin-1-ium) 2,5-dicarboxybenzene-1,4-dicarboxylate--2,9-dimethyl-1,10-phenanthroline--benzene-1,2,4,5-tetracarboxylic acid (1/2/1)
2(C14H13N2),C10H6O82,2(C14H12N2),C10H4O8
Acta Crystallographica Section E (2013) 69, 9 o1445-o1446
a=11.798(4)Å b=13.893(4)Å c=19.163(6)Å
α=90° β=92.216(5)° γ=90°
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--1,4-diazabicyclo[2.2.2]octane (2/1)
2(C12H14N4O2S),C6H12N2
Acta Crystallographica Section E (2013) 69, 11 o1615
a=26.488(3)Å b=9.7886(11)Å c=12.2163(13)Å
α=90.00° β=90.00° γ=90.00°
4-Aza-1-azoniabicyclo[2.2.2]octane--2-aminobenzoate--2-aminobenzoic acid (1/1/1)
C6H13N2,C7H6NO2,C7H7NO2
Acta Crystallographica Section E (2011) 67, 11 o2933
a=9.285(3)Å b=16.843(5)Å c=12.660(4)Å
α=90° β=102.127(6)° γ=90°
2-Aminobenzoic acid--4-(pyridin-4-yldisulfanyl)pyridine (1/1)
C7H7NO2,C10H8N2S2
Acta Crystallographica Section E (2011) 67, 12 o3361
a=8.636(2)Å b=12.728(3)Å c=15.688(4)Å
α=90° β=103.218(4)° γ=90°
<i>tert</i>-Butyl(2-hydroxyethyl)azanium 4-[(1,3-thiazol-2-ylazanidyl)sulfonyl]aniline
C6H16NO,C9H8N3O2S2
Acta Crystallographica Section E (2012) 68, 9 o2662-o2663
a=13.893(3)Å b=11.771(3)Å c=22.191(5)Å
α=90° β=91.401(4)° γ=90°
4-Amino-<i>N</i>-(2,3-dihydro-1,3-thiazol-2-ylidene)benzenesulfonamide; 2,4,6-tris(pyridin-2-yl)-1,3,5-triazine
C18H12N6,C9H9N3O2S2
Acta Crystallographica Section E (2014) 70, 4 o402-o403
a=8.8109(13)Å b=12.7222(16)Å c=13.1696(14)Å
α=66.227(6)° β=73.797(6)° γ=88.068(9)°